Related Experiment Video
Updated: Jun 29, 2025

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
Srs2 binding to PCNA and its sumoylation contribute to RPA antagonism during the DNA damage response
Jiayi Fan1, Nalini Dhingra1, Tammy Yang2
1Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.
Abstract:
Activation of the DNA damage checkpoint upon genotoxin treatment induces a multitude of cellular changes to cope with genome stress. After prolonged genotoxin treatment, the checkpoint can be downregulated to allow cell cycle and growth resumption. In yeast, downregulation of the DNA damage checkpoint requires the Srs2 DNA helicase, which removes the ssDNA binding complex RPA and the associated Mec1 checkpoint kinase from DNA, thus dampening Mec1-mediated checkpoint. However, it is unclear whether the 'anti-checkpoint' role of Srs2 is temporally and spatially regulated to allow timely checkpoint termination while preventing superfluous RPA removal. Here we address this question by examining regulatory elements of Srs2, such as its phosphorylation, sumoylation, and protein-interaction sites. Our genetic analyses and checkpoint level assessment suggest that the RPA countering role of Srs2 is promoted by Srs2 binding to PCNA, which recruits Srs2 to a subset of ssDNA containing regions. RPA antagonism is further fostered by Srs2 sumoylation, which we found depending on the Srs2-PCNA interaction and Mec1, and peaking after Mec1 activity reaches maximal levels. These data suggest that Srs2 recruitment to PCNA proximal ssDNA-RPA filaments followed by its sumoylation can promote checkpoint recovery, whereas Srs2 action is minimized at regions with no proximal PCNA to permit RPA-mediated ssDNA protection.
Insights
The DNA damage checkpoint is downregulated by Srs2 DNA helicase, which removes RPA and Mec1 checkpoint kinase from DNA. This process is regulated by Srs2 binding to PCNA and sumoylation, ensuring timely checkpoint termination and DNA protection.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- DNA damage checkpoints are crucial for genome stability, halting cell cycle progression upon genotoxin exposure.
- Checkpoint downregulation allows cell cycle resumption after prolonged stress, but its regulation is not fully understood.
- In yeast, Srs2 DNA helicase is known to downregulate the DNA damage checkpoint by removing RPA and Mec1.
Purpose of the Study:
- To investigate the temporal and spatial regulation of Srs2's anti-checkpoint role.
- To elucidate the regulatory mechanisms controlling Srs2 activity in checkpoint downregulation.
- To understand how Srs2 prevents superfluous RPA removal while allowing checkpoint recovery.
Main Methods:
- Genetic analyses of Srs2 regulatory elements (phosphorylation, sumoylation, protein interactions).
- Checkpoint level assessment in yeast cells.
- Examination of Srs2 binding to PCNA and its effect on RPA removal.
Main Results:
- Srs2's RPA countering role is promoted by its binding to PCNA, recruiting it to specific ssDNA regions.
- Srs2 sumoylation, dependent on Srs2-PCNA interaction and Mec1 activity, further enhances RPA antagonism.
- A two-step model for checkpoint downregulation is proposed, involving Srs2 recruitment and sumoylation upon Mec1 hyperactivation.
Conclusions:
- Srs2 activity is spatially and temporally regulated to ensure efficient checkpoint termination.
- PCNA binding and sumoylation are key regulators of Srs2's role in DNA damage checkpoint recovery.
- This regulation minimizes RPA removal at unprotected ssDNA, preserving DNA integrity.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Restarting Stalled Replication Forks
Negative Regulator Molecules
Single-Strand DNA Binding Proteins
Abnormal Proliferation
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

